Inner Mongolia Baotou Steel Union Co., Ltd.

$ 2.43 1.25 %

Qingdao Haier Biomedical Co., Ltd. specializes in the global development, production, sales, and distribution of low-temperature storage solutions for critical biomedical samples. Their extensive product portfolio includes a range of freezers—such as cryogenic, ultra-low temperature, biomedical, spark-free, vaccine, and plasma models—along with refrigerators designed for laboratories, pharmacies, blood banks, and vaccine storage. They also provide blood/fluid warming cabinets, essential backup systems, consumables, and specialized cold/freezer rooms, alongside comprehensive vaccine safety solutions and plasma apheresis systems. Beyond storage, the company delivers various healthcare innovations, including intelligent mobile inoculation clinics, refrigerated vaccine transport vehicles, advanced vaccine shelters, P2+ mobile nucleic acid testing vehicles, smart autonomous disinfection units, and air purification sterilizers. Their offerings further extend to medical diagnostic and support tools like infrared thermometers, blood pressure monitors, and oxygen concentrators, as well as biosafety screening booths, solar-powered medical laboratories, mobile PCR testing labs, and versatile mobile container clinics. Complementing these, they supply a selection of general laboratory equipment and transport coolers. Established in 2005, Qingdao Haier Biomedical Co., Ltd. is headquartered in Qingdao, China. Separately, Inner Mongolia Baotou Steel Union Co., Ltd. operates as a subsidiary of Baotou Iron and Steel (Group) Co., Ltd.

CEO: Zhao Zhang - https://www.baoganggf.com

Price objectif

-

Recommandation

-

DCF

$ 4.13

Loading data...

600010.SS vs S&P500

Loading data...

No data available.

Quick ratio

0.41

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

243.00

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.01

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-0.26 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

0.63 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

4.82

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.68

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.00

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

-672.58 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
3 indicates worrying financial health
Altman score
1.08 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.15 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.23 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.